CONCORDBIO:NSE
Concord Biotech Ltd
₹1,341.50
arrow_downward
-0.87%(-11.80) 1D
Okt 16, 3:30:00 PM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa CONCORDBIO...
Buksan
₹1,362.90
Mataas
₹1,366.80
Mababa
₹1,332.00
Mkt. cap
140.34B
Avg. na dami
131.96K
Dami
45.38K
Dividend
0.56%
Bawat tatlong buwang dividend
₹1.89
Petsa ng ex-dividend
Hul 24, 2026
P/E ratio
50.99
Mataas nang 52-wk
₹1,615.00
Mababa nang 52-wk
₹987.00
EPS
₹26.31
Bilang ng mga empleyado
2K
Buksan
₹1,362.90
Mataas
₹1,366.80
Mababa
₹1,332.00
Mkt. cap
140.34B
Avg. na dami
131.96K
Dami
45.38K
Dividend
0.56%
Bawat tatlong buwang dividend
₹1.89
Petsa ng ex-dividend
Hul 24, 2026
P/E ratio
50.99
Mataas nang 52-wk
₹1,615.00
Mababa nang 52-wk
₹987.00
EPS
₹26.31
Bilang ng mga empleyado
2K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
NDTV Profit
·
7 oras ang nakalipas
84 Percent Stocks In Correction, Yet S&P 500 Nears Record High: What's Behind The 'Bull-Bear' Market?
investingLive
·
23 oras ang nakalipas
S&P 500 analysis and forecast after the "AI bubble" panic
Bloomberg
·
6 araw ang nakalipas
S&P 500 Wavers as Earnings Bets Offset Chip Rout: Markets Wrap
Reuters
·
4 araw ang nakalipas
Nasdaq ends down as chipmakers fall and bank earnings roll in
Profile
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
Tungkol sa Concord Biotech Ltd